表 2. Baseline characteristics of patients in different CYP4F2 genotypes .
不同CYP4F2基因型患者基线资料的比较
| Variable | CYP4F2 CC (n=194) | CYP4F2 CT (n=125) | CYP4F2 TT (n=31) | P |
| CYP2C9: Cytochrome P-450 2C9; VKORC1: Vitamin K epoxide reductase complex 1; CYP4F2: Cytochrome P-450 4F2; BMI: Body mass index; MVR: Mitral valve replacement; AVR: Aortic valve replacement; CHD: Coronary heart disease. | ||||
| Male/case (%) | 96 (49.5) | 51 (40.8) | 15 (48.4) | 0.577 |
| Age/yr. | 52.94±12.70 | 53.52±13.77 | 51.38±17.03 | 0.740 |
| Height/cm | 164.10±8.21 | 164.87±7.92 | 163.31±8.18 | 0.566 |
| Body mass/kg | 64.94±12.25 | 65.07±11.63 | 62.21±11.59 | 0.488 |
| BMI/(kg/m2) | 24.02±3.60 | 23.86±3.48 | 23.25±3.63 | 0.558 |
| MVR/case (%) | 114 (58.8) | 71 (56.8) | 22 (71.0) | 0.379 |
| AVR/case (%) | 80 (41.2) | 54 (43.2) | 9 (29.0) | 0.672 |
| Hypertension/case (%) | 101 (52.1) | 62 (49.6) | 11 (35.5) | 0.427 |
| CHD/case (%) | 63 (32.5) | 45 (36.0) | 8 (25.8) | 0.671 |
| Diabetes mellitus/case (%) | 26 (13.4) | 14 (11.2) | 2 (6.5) | 0.213 |
| Atrial fibrillation/case (%) | 49 (25.3) | 24 (19.2) | 5 (16.1) | 0.332 |